Generic Name
Tc-99M Exametazime
Brand Names
Ceretec, Drax Exametazime
FDA approval date: December 30, 1988
Classification: Radioactive Diagnostic Agent
Form: Injection, Kit
What is Ceretec (Tc-99M Exametazime)?
Technetium Tc99m exametazime scintigraphy may be useful as an adjunct in the detection of altered regional cerebral perfusion in stroke. Tc99m exametazime is indicated for leukocyte labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment